TOKYO — A Japanese pharmaceutical firm has warned doctors against prescribing a drug for rare autoimmune diseases to new patients following the deaths of 20 people who took it. Kissei Pharmaceutical, ...

Amgen (AMGN) stock is in focus as partner Kissei (KSPHF) reports 20 deaths linked to the U.S. company's rare disease drug.

Tokyo: The Japanese pharmaceutical company Kissei Pharmaceutical has advised doctors not to prescribe its rare disease ...

Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it ...

Kissei Pharmaceutical's notice to healthcare professionals came after 20 deaths possibly linked to the drug were reported in ...

Kissei Pharmaceutical, which sells the rare immune-disease drug in Japan, warned doctors to stop prescribing it to new ...

About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with ​Amgen's rare ...

Chip stocks retreated premarket, following a ferocious rally in their shares. Intel, w ...

Alumis is exploring strategic alternatives for its would-be rival to Amgen’s Tepezza, choosing to punt the program rather ...

CGRP inhibitors did not increase glaucoma risk in a large cohort of patients with migraine, according to findings published in Neurology. “Migraine and glaucoma have been linked through shared ...